Barry Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Barry Investment Advisors's AMGN Position: Q2 2026 in Review
Barry Investment Advisors reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $11.3K and leaving 1,360 shares worth $493K. The position accounts for 0.1% of the portfolio, ranked #59.
Barry Investment Advisors first reported a position in AMGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $789K in Q4 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Barry Investment Advisors held 1,360 shares of Amgen worth $493K as of Q2 2026.
- Barry Investment Advisors sold 33 Amgen shares in Q2 2026, an estimated $11.3K.
- Amgen made up 0.1% of Barry Investment Advisors's portfolio in Q2 2026, its #59 holding.
- Barry Investment Advisors first reported a position in Amgen in Q3 2019 and has held it in 28 quarters since.
- Barry Investment Advisors's Amgen position peaked at $789K in Q4 2022.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.